Curriculum standards: LG17: Immunisation

Advanced Trainees will describe the principles of the foundational sciences.

Advanced Trainees will assess patients’ current conditions and plan the next steps.

Advanced Trainees will understand the resources that should be used to help manage patients.

Advanced Trainees will monitor the progress of patients during the therapy.

Advanced Trainees will know how to monitor and manage patients post-therapy.

Advanced Trainees will identify important specialty-specific issues and the impact of these on diagnosis, management and outcomes.

Adaptive and innate immune responses to immunisations used in clinical practice, such as live attenuated and non-live immunisations against infectious diseases
Monoclonals used as passive immunisation, such as nirsevimab and palivizumab
New immunisation strategies and vaccines
Passive and active immunisation in different populations
Types of vaccines, such as:
- component
- conjugated polysaccharide
- inactivated
- killed organisms
- live attenuated
- messenger RNA (mRNA)
- protein conjugate
- purified bacterial protein
- recombinant
- toxoid
- viral vectors
Use of vaccines in post-exposure prophylaxis, including to boost pre-existing immunity, such as:
- chickenpox
- hepatitis:
  - A
  - B
- meningococcal ACWY
- rabies
- tetanus

PCH

General structure of and rationale for local / national immunisation dosing schedule, including:
- avoidance of polysaccharide vaccines in children under 2 years of age
- vaccines for special groups
Maturation of immune response

Advice for patients on immunisation, including:
- common myths and misinformation
- sharing knowledge about immunisation (SKAI)
Benefits of immunisation
Immunisation requirements for:
- special populations
- the general population
- travellers
Immunisation strategies for patients who have undergone cancer chemotherapy
Pre-hematopoietic stem cell transplantation (HSCT) considerations, such as:
- immunisation strategies:
  - post-transplant
  - pre-transplant
- infectious diseases evaluation, and pre- and post-transplant
Standard vaccine schedule and catch-up schedules, considering:
- age at immunisation
- prior adverse events
- spacing of vaccines

PCH

Specific immunisation considerations for:
- long-term hospitalised infants and children
- premature babies

PCH

Bacille Calmette–Guérin (BCG) and travel vaccines for children
Knowledge of when routine vaccines may be given early
National and state-based immunisation schedules, including:
- advice for travellers
- eligibility, including Medicare (Australia)
- how to access them

Counsel patients and families
Effects of immunisation on a population, such as:
- age shifts in natural infection
- herd immunity
- serotype replacement
Future immunisation schedule
Management of adverse reactions to immunisations, such as:
- common reactions, implications, and management
- criteria and legislation for vaccine exemption
- legislation about immunisation for children, and eligibility / implications for childcare and education
- local and national vaccine adverse event reporting
- severe reactions, and when specialist referral is required

Biological and iatrogenic aetiologies of immune deficiency
Licensed vaccines in prevention of disease caused by:
- infection:
  - bacterial
  - viral
- toxins - bacterial
National and international schedules for immunisation
Recommendations for immunisation of healthcare workers

Curriculum standards